Takeda ‘to sell OTC business in Europe’ to fund Shire acquisition

Japan-based Takeda Pharmaceuticals is reportedly planning to sell its European over-the-counter business to lessen its debt from acquiring biotech company Shire.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

EUIPO sides with Takeda in trademark appeal

28 November 2018 Japan-based Takeda Pharmaceutical has persuaded the European Union Intellectual Property Office that an applied-for trademark would be confused with its own earlier-registered mark

Big Pharma

Japanese Takeda to acquire Shire for $62bn

8 May 2018 Japanese pharmaceutical company Takeda has agreed to acquire biotech company Shire for $62 billion.

Asia-Pacific

Takeda makes fourth offer to buy Shire

23 April 2018 Japan-based Takeda has upped its offer to buy Ireland-headquartered Shire for the fourth time, raising its bid to approximately £44 billion.

More features

The Quintara decision: Defining trade secrets in federal cases

To disclose or not: Pharma patents face new AI reality

Trade secrets go global: How brand owners face a high-stakes battlefront

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

Sandoz eyes US biosimilar launch as Regeneron settles

Killing the golden goose of US drug innovation (Part I): Follow the money

Buchalter brings in new partner to head up medtech

Takeda ‘to sell OTC business in Europe’ to fund Shire acquisition

More on this story

Editor's picks

Editor's picks

More features